Kim Song-Jung, Depre Christophe, Vatner Stephen F
Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103, USA.
Heart Fail Rev. 2003 Apr;8(2):143-53. doi: 10.1023/a:1023040718319.
Myocardial stunning is defined as the prolonged contractile dysfunction following an ischemic episode that does not result in necrosis, which also occurs in patients with coronary artery disease. There is also evidence to consider myocardial stunning as a fundamental component of hibernating myocardium. Various experimental approaches (from a brief episode to prolonged partial ischemia) and animal models (from rodents to large mammals) have been developed to investigate the pathogenesis of myocardial stunning. Three hypotheses to explain the mechanism, i.e. oxygen radical, Troponin I degradation, and Ca(2+), have been proposed. The first was tested primarily using large mammalian models, whereas the others were tested primarily using rodent models. Recently, the Ca(2+) handling hyothesis has been tested in a large mammalian swine model of myocardial stunning, in which both Ca(2+) and transients and L-type Ca(2+) current density were decreased. Relaxation function and phospholamban phosphorylation are also radically different in large mammalian and rodent models. In addition, troponin I degradation, which was identified as the mechanism of stunning in rodent models, was not found in stunned swine myocardium. Interestingly, the large mammalian model demonstrates that stunning elicits broad changes in gene and protein regulation, some of which have not been observed in the heart previously. The overall genomic adaptation upregulates the expression of survival genes that prevent irreversible damage. Pursuing these new concepts derived from large mammalian models of ischemia/reperfusion will provide more comprehensive mechanistic information underlying myocardial stunning and will serve to devise new therapeutic modalities for patients.
心肌顿抑被定义为缺血发作后出现的、不导致坏死的持续性收缩功能障碍,这种情况也见于冠状动脉疾病患者。也有证据将心肌顿抑视为冬眠心肌的一个基本组成部分。已开发出各种实验方法(从短暂发作到长时间部分缺血)和动物模型(从啮齿动物到大型哺乳动物)来研究心肌顿抑的发病机制。已提出三种解释其机制的假说,即氧自由基、肌钙蛋白I降解和钙离子假说。第一种主要在大型哺乳动物模型中进行了验证,而其他假说主要在啮齿动物模型中进行了验证。最近,钙离子处理假说在一个大型哺乳动物猪心肌顿抑模型中得到了验证,在该模型中,钙离子和瞬时变化以及L型钙离子电流密度均降低。大型哺乳动物模型和啮齿动物模型中的舒张功能和受磷蛋白磷酸化也存在根本差异。此外,在猪顿抑心肌中未发现被确定为啮齿动物模型中顿抑机制的肌钙蛋白I降解现象。有趣的是,大型哺乳动物模型表明,顿抑会引发基因和蛋白质调控方面的广泛变化,其中一些变化以前在心脏中未被观察到。整体基因组适应性上调了预防不可逆损伤的生存基因的表达。探索这些源自缺血/再灌注大型哺乳动物模型的新概念,将为心肌顿抑提供更全面的机制信息,并有助于为患者设计新的治疗方法。